HCA Healthcare, Inc. $HCA Shares Sold by Verdence Capital Advisors LLC

20 Jan 2026, 13:34 by Sarita Garza · The Markets Daily

Verdence Capital Advisors LLC trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 70.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,251 shares of the company’s stock after selling 14,592 shares during the period. Verdence Capital Advisors LLC’s holdings in HCA Healthcare were worth $2,925,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of HCA. Norges Bank acquired a new stake in HCA Healthcare during the 2nd quarter worth approximately $1,152,408,000. Pacer Advisors Inc. boosted its position in HCA Healthcare by 6,115.3% during the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock worth $388,309,000 after purchasing an additional 896,437 shares during the period. Viking Global Investors LP grew its stake in shares of HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after buying an additional 690,773 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of HCA Healthcare during the second quarter valued at approximately $109,337,000. Finally, Metropolis Capital Ltd lifted its holdings in HCA Healthcare by 76.6% in the 2nd quarter. Metropolis Capital Ltd now owns 603,029 shares of the company’s stock worth $231,020,000 after buying an additional 261,592 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently commented on HCA. Bank of America increased their price target on HCA Healthcare from $430.00 to $470.00 and gave the company a “neutral” rating in a report on Monday, October 27th. The Goldman Sachs Group increased their price objective on shares of HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Cowen restated a “buy” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of HCA Healthcare in a report on Monday, December 29th. Finally, Wells Fargo & Company lifted their price objective on shares of HCA Healthcare from $431.00 to $452.00 and gave the stock an “equal weight” rating in a report on Wednesday, January 7th. Fifteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $487.00.

View Our Latest Stock Analysis on HCA

HCA Healthcare Trading Down 3.0%

HCA opened at $469.08 on Tuesday. HCA Healthcare, Inc. has a twelve month low of $295.00 and a twelve month high of $520.00. The stock has a market cap of $107.04 billion, a PE ratio of 18.13, a price-to-earnings-growth ratio of 1.29 and a beta of 1.36. The business’s 50 day moving average is $480.68 and its 200-day moving average is $431.78.

HCA Healthcare (NYSE:HCA – Get Free Report) last announced its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Monday, December 15th. HCA Healthcare’s payout ratio is presently 11.13%.

Insiders Place Their Bets

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.